Malignant Neoplasm of Unknown Primary — Trials

Malignant Neoplasm of Unknown Primary — Trials · CancerIndex

Clinical trials

Registered studies

14,260 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 4,163
Recruiting: 2,261
Ph III recruiting: 270
Growth YoY: +12.5%
Industry share: 23%
Top sponsor: National Cancer Institute (NCI)
Termination share: 35.4%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1,895)

clinicaltrialsPublishedShowing 201–250 of 413 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04331184	RFA Using Combined Bipolar and Monopolar Energy Deliver With Twin Cooled-Wet Electrodes	unknown	N/A	102	Seoul National University HospitalOTHER	1	Mar 17, 2021	clinicaltrials
NCT04471272	RFA Using Gradual RF Energy Delivery Mode With Octopus Electrodes	unknown	N/A	120	Seoul National University HospitalOTHER	1	Mar 17, 2021	clinicaltrials